Form 4 Tracker
Craig C. Hopkinson

EVP R&D, Chief Medical Officer · 12 filings · Latest: Sep 1, 2026

Alkermes plc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ALKS
Hopkinson Craig C.—Mar 2, 2026
Proposed Sale
$29.729,000$267.5K—
ALKS
Craig C. HopkinsonEVP R&D, Chief Medical OfficerFeb 26, 2026
Option Exercise
—6,866—96,438
ALKS
Craig C. HopkinsonEVP R&D, Chief Medical OfficerFeb 23, 2026
Option Exercise
—7,689—92,986
ALKS
Craig C. HopkinsonEVP R&D, Chief Medical OfficerFeb 19, 2026
Option Exercise
—7,673—88,704
ALKS
Craig C. HopkinsonEVP R&D, Chief Medical OfficerFeb 18, 2026
Option Exercise
—8,897—84,535
ALKS
Craig C. HopkinsonEVP R&D, Chief Medical OfficerFeb 2, 2026
Sale
$33.939,000$305.4K57,740
ALKS
Craig C. HopkinsonEVP R&D, Chief Medical OfficerFeb 2, 2026
Option Exercise
$19.345,000$96.7K66,740
ALKS
Hopkinson Craig C.—Feb 2, 2026
Proposed Sale
$33.939,000$305.4K—
ALKS
Hopkinson Craig C.—Jan 8, 2026
Proposed Sale
$30.005,000$150.0K—
ALKS
Hopkinson Craig C.—Jan 2, 2026
Proposed Sale
$28.004,000$112.0K—
ALKS
Hopkinson Craig C.—Dec 3, 2025
Proposed Sale
$30.003,748$112.4K—
ALKS
Hopkinson Craig C.—Dec 1, 2025
Proposed Sale
$29.304,000$117.2K—
ALKS
Hopkinson Craig C.—Nov 3, 2025
Proposed Sale
$30.389,000$273.4K—
ALKS
Hopkinson Craig C.—Oct 15, 2025
Proposed Sale
$31.539,000$283.8K—
ALKS
Hopkinson Craig C.—Feb 13, 2025
Proposed Sale
$35.53144,419$5.1M—
ALKS
Hopkinson Craig C.—Feb 12, 2025
Proposed Sale
$32.78204,921$6.7M—
ALKS
Hopkinson Craig C.—Jan 30, 2025
Proposed Sale
$32.05100,918$3.2M—
ALKS
Hopkinson Craig C.—Dec 9, 2024
Proposed Sale
$32.0761,151$2.0M—
ALKS
Hopkinson Craig C.—Dec 5, 2024
Proposed Sale
$31.509,221$290.5K—
ALKS
Hopkinson Craig C.—Dec 4, 2024
Proposed Sale
$30.7714,349$441.6K—